MYMYELITIS.COM: Keyword Density Checker

Total words: 1694 | 2-word phrases: 430 | 3-word phrases: 499 | 4-word phrases: 537

PAGE INFO

Title	Try to keep the title under 60 characters (59 characters) MyMyelitis - Aiding Your Recovery From MOG Antibody Disease
Description	Try to keep the meta description between 50 - 160 characters (138 characters) Welcome to MyMyelitis, a website dedicated to helping those suffering from MOG Antibody Disease and other related neurological conditions.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (10 characters) MyMyelitis

#	Keyword	Frequency	Density
1	mog antibody disease	25	5.01%
2	mog antibody disease?	25	5.01%
3	antibody disease mog	8	1.60%
4	or mog antibody	4	0.80%
5	fatigue in mog	4	0.80%
6	antibody disease mogad	4	0.80%
7	ignition survey 2	3	0.60%
8	antibody disease research	3	0.60%
9	treatment for mog	3	0.60%
10	for mog antibody	3	0.60%
11	the mog project	3	0.60%
12	disease mogad relapses	3	0.60%
13	in mog antibody	2	0.40%
14	disease research –	2	0.40%
15	up to date	2	0.40%
16	stay up to	2	0.40%
17	research – msj	2	0.40%
18	antibody disease information	2	0.40%
19	– msj publication	2	0.40%
20	phase 3 clinical	2	0.40%
21	transverse myelitis information	2	0.40%
22	meteroid clinical trial	2	0.40%
23	satralizumab meteroid clinical	2	0.40%
24	support groups mog	2	0.40%
25	more mog antibody	2	0.40%
26	in read more	2	0.40%
27	fatigue in mogad	2	0.40%
28	in mogad –	2	0.40%
29	mogad – ignition	2	0.40%
30	– ignition survey	2	0.40%

#	Keyword	Frequency	Density
1	mog antibody disease mog	7	1.30%
2	or mog antibody disease	4	0.74%
3	mog antibody disease mogad	4	0.74%
4	mog antibody disease research	3	0.56%
5	for mog antibody disease	3	0.56%
6	treatment for mog antibody	3	0.56%
7	for mog antibody disease?	3	0.56%
8	satralizumab meteroid clinical trial	2	0.37%
9	disease mogad relapses mog	2	0.37%
10	rozanolixizumab – a new	2	0.37%
11	fatigue in mog antibody	2	0.37%
12	phase 3 clinical trial	2	0.37%
13	disease mog antibody disease	2	0.37%
14	in mog antibody disease	2	0.37%
15	antibody disease mog antibody	2	0.37%
16	fatigue in mogad –	2	0.37%
17	in mogad – ignition	2	0.37%
18	mogad – ignition survey	2	0.37%
19	– ignition survey 2	2	0.37%
20	stay up to date	2	0.37%
21	antibody disease research –	2	0.37%
22	disease research – msj	2	0.37%
23	research – msj publication	2	0.37%
24	mogad relapses mog antibody	2	0.37%
25	– msj publication last	1	0.19%
26	announcements mog antibody disease	1	0.19%
27	disease fatigue in mog	1	0.19%
28	antibody disease fatigue in	1	0.19%
29	we were featured in	1	0.19%
30	more rozanolixizumab – a	1	0.19%
31	read more rozanolixizumab –	1	0.19%
32	trialed read more rozanolixizumab	1	0.19%
33	be trialed read more	1	0.19%
34	will be trialed read	1	0.19%
35	rozanolixizumab will be trialed	1	0.19%
36	msj publication last week	1	0.19%
37	mymyletismymyletis home about us	1	0.19%
38	were featured in our	1	0.19%
39	fatigue in read more	1	0.19%
40	mog project mymyelitis created	1	0.19%

#	URL	Whois	Check
1	https://mogproject.org/	Whois	mogproject.org
2	https://www.youtube.com/c/MyMyelitis	Whois	youtube.com
3	https://www.instagram.com/mymyelitis/	Whois	instagram.com
4	https://www.facebook.com/MyMyelitis	Whois	facebook.com
5	https://twitter.com/MyMyelitis	Whois	twitter.com
6	https://www.tiktok.com/@mymyelitis	Whois	tiktok.com